NASDAQ: NRSN
Neurosense Therapeutics Ltd Stock Ownership - Who owns Neurosense Therapeutics?

Insider buying vs selling

Have Neurosense Therapeutics Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alon BennoonChief Executive Officer2026-06-16250,000$0.80
$200.00kBuy
Or EisenbergChief Financial Officer2026-06-16250,000$0.80
$200.00kBuy

1 of 1

NRSN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRSN insiders and whales buy or sell their stock.

NRSN Shareholders

What type of owners hold Neurosense Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Alon Bennoon278.54%4,534,233$30.02MInsider
Or Eisenberg92.39%1,504,050$9.96MInsider
Hagit Binder32.05%521,806$3.45MInsider
Ferenc Tracik26.29%428,011$2.83MInsider
Mark Leuchtenberger7.55%122,951$813.94kInsider
Christine A. Pellizzari6.14%99,898$661.32kInsider
Cary J. Claiborne6.14%99,898$661.32kInsider
Roy Golan4.72%76,844$508.71kInsider
Revital Mandillevin4.72%76,844$508.71kInsider
Niva Russekblum0.61%10,000$66.20kInsider

1 of 3

NRSN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRSN0.01%99.99%Net Buying
PHIO0.00%100.00%Net SellingNet Selling
JAGX0.00%100.00%
ASBP0.00%100.00%
KPRX0.01%99.99%Net SellingNet Selling

Neurosense Therapeutics Stock Ownership FAQ

Who owns Neurosense Therapeutics?

Neurosense Therapeutics (NASDAQ: NRSN) is owned by 0.02% institutional shareholders, 459.16% Neurosense Therapeutics insiders, and 0.00% retail investors. Alon Bennoon is the largest individual Neurosense Therapeutics shareholder, owning 4.53M shares representing 278.54% of the company. Alon Bennoon's Neurosense Therapeutics shares are currently valued at $32.56M.

If you're new to stock investing, here's how to buy Neurosense Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.